California Legislature · 2019-2020 Regular Session
Amended Assembly
AB 347
Preschool: privately funded pilot program: tax credits
Author:
Steven Choi
(R-AD68)
Show 1 co-author
Randy Voepel
(R-AD71)
Latest action:
Amended Assembly
(Mar 19, 2019)
Current location: CX19 · Desk
Version history
Action history
-
Feb 4, 2019 Read first time. To print. Assembly
-
Feb 5, 2019 From printer. May be heard in committee March 7. Assembly
-
Feb 28, 2019 Referred to Com. on REV. & TAX. Assembly
-
Mar 11, 2019 In committee: Hearing for testimony only. Assembly
-
Mar 19, 2019 From committee chair, with author's amendments: Amend, and re-refer to Com. on REV. & TAX. Read second time and amended. Assembly
-
Mar 20, 2019 Re-referred to Com. on REV. & TAX. Assembly
-
Jan 31, 2020 Died pursuant to Art. IV, Sec. 10(c) of the Constitution. Assembly
-
Feb 3, 2020 From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. Assembly
Lobbying activity
FPPC lobbying disclosures whose activity descriptions mention AB 347, scoped to filings whose coverage period extends through or beyond this bill's introduction date.
Note: CalAccess lobby filings reference bills by measure number only — no session tag. When the same measure number has existed in earlier sessions (e.g. a previously chaptered bill still being lobbied on for implementation), some of those filings may appear here even though they relate to a different bill. Use the activity descriptions to disambiguate.
| Period | Form | Filer | Firm / Employer | Lobbying Activity | Filing |
|---|---|---|---|---|---|
| 01/01/2021–03/31/2021 | Employer Report | ABBVIE | — | AB 71, AB 248, AB 249, AB 264, AB 347, AB 407, AB 458, AB 593, AB 654, AB 671, AB 789, AB 904, AB 933, AB 1050, AB 1130, AB 1178, AB 1400, SB 46, SB 48, SB 250, SB 252, SB 260, SB 310, SB 368, SB 521, SB 535, SB 568, SB 605, SB 852 Implementation, Hep C Issues | #2573212 |
| 01/01/2021–03/31/2021 | Employer Report | ALEXION PHARMACEUTICALS, INC. | — | CALIFORNIA STATE LEGISLATURE REGARDING AB 347, AB 458, AB 752, AB 933, AB 1130, AB 1400, AB 1468, SB 247, SB 250, SB 368, SB 521. | #2576809 |
| 01/01/2021–03/31/2021 | Employer Report | AMERICA'S HEALTH INSURANCE PLANS (AHIP) | AMERICA'S HEALTH INSURANCE PLANS | AB 32, 97, 342, 347, 454, 457, 752, 933, 935, 1011, 1254, 1400, 1520; SB 221, 242, 245, 250, 306, 368, 428, 473, 510, 523, 535, 542, 562, 613 | #2581559 |
| 01/01/2021–03/31/2021 | Employer Report | ARTHRITIS FOUNDATION | — | AB 347, Accumulator Adjustment Programs, SB 568, AB 752, SB 250, AB 1306, SB 682 | #2571635 |
| 01/01/2021–03/31/2021 | Employer Report | ASTELLAS PHARMA US, INC. | — | AB 247, AB 347, AB 458, AB 933, SB 568 | #2577531 |
| 01/01/2021–03/31/2021 | Employer Report | ASTRA ZENECA PHARMACEUTICALS, LP | — | Legislature: SB521, SB535, AB347, AB609, COVID-19 vaccine and treatments, precision medicine/oncology issues, respiratory disease. | #2578460 |
| 01/01/2021–03/31/2021 | Employer Report | BIOCOM | — | Legislature: Budget, AB 70, AB 97, AB 247, AB 347, AB 593, AB 933, SB 252, SB 255, SB 473, SB 568, SB 605, SB 718 Dept of Finance: AB 593 Admnistration: vaccination prioritization | #2581971 |
| 01/01/2021–03/31/2021 | Employer Report | Biogen | Biogen Inc. | Legislature: AB 347; AB 752; SB 48; SB 247; SB 521. Go Biz: AB 347; AB 752; SB 48; SB 247; SB 521. Department of Finance: AB 347; AB 752; SB 48; SB 247; SB 521. | #2579198 |
| 01/01/2021–03/31/2021 | Employer Report | BREATHE SOUTHERN CALIFORNIA | BREATHE CALIFORNIA OF LOS ANGELES COUNTY (BREATHE LA) | AB 52, 73, 111, 117, 122, 285, 347, 365, 426, 563, 619, 648, 766, 906, 926, 933, 970, 992, 1110, 1141, 1142, 1296; SB 18, 63, 109, 260, 261, 487, 551, 568, 671; Department of Public Health re: Chronic Obstructive Pulmonary Disease (COPD) Outreach | #2579710 |
| 01/01/2021–03/31/2021 | Employer Report | BRISTOL-MYERS SQUIBB COMPANY | — | Legislature: AB347. | #2579914 |
| 01/01/2021–03/31/2021 | Employer Report | California Chronic Care Coalition | Plasma Protein Therapeutics Association | Bills lobbied: AB 32, AB 97, AB 342, AB 347, AB 370, AB 402, AB 457, AB 508, AB 593, AB 619, AB 671, AB 752, AB 933, AB 1011, AB 1054, AB 1163, AB 1178, AB 1197, AB 1254, AB 1430, AB 1520, ACR 11, HR 19,SB 17, SB 21, SB 40, SB 48, SB 255, SB 258, SB 279, SB 280, SB 362, SB 402, SB 409, SB 455, SB 460, SB 473, SB 510, SB 524, SB 535, SB 568, SB 682, SCR 11, SCR 13 | #2581560 |
| 01/01/2021–03/31/2021 | Employer Report | CALIFORNIA PHARMACISTS ASSOCIATION | CALIFORNIA PHARMACISTS ASSOCIATION | AB 347, 369, 458, 671, 752, 933, 1064, 1430; SB 306, 362, 524, 535; MEDI-CAL RX, PHARMACY REGULATIONS RELATED TO COMPOUNDING AND COVID WAIVER: LEGISLATURE, CALIFORNIA STATE BOARD OF PHARMACY, CALIFORNIA DEPARTMENT OF HEALTH CARE SERVICES | #2579052 |
| 01/01/2021–03/31/2021 | Employer Report | CALIFORNIA RHEUMATOLOGY ALLIANCE | — | MEDICAL BOARD OF CALIFORNIA ISSUES. DEPARTMENT OF MANAGED HEALTH CARE: STEP THERAPY AND PRIOR AUTHORIZATION ISSUES. AB 80, AB 347, AB 454, AB 650, AB 752, AB 933, AB 1130, AB 1162, AB 1278, AB 1328, SB 242, SB 568. | #2577004 |
| 01/01/2021–03/31/2021 | Employer Report | CROHNS AND COLITIS FOUNDATION | CROHNS AND COLITIS FOUNDATION | AB 347 | #2581255 |
| 01/01/2021–03/31/2021 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 71, 342, 347, 458, 593, 752, 814, 933, 1130, 1254, 1371; SB 17, 54, 250, 252, 260, 310, 356, 428, 521, 535, 568; SCR 11; MEDI-CAL RX: CALIFORNIA DEPARTMENT OF HEALTH CARE SERVICES | #2579407 |
| 01/01/2021–03/31/2021 | Employer Report | HEMOPHILIA COUNCIL OF CALIFORNIA | HEMOPHILIA COUNCIL OF CALIFORNIA | STATE BUDGET: MEDI-CAL CCS AND GHPP. TELEHEALTH PER COVID-19. CALAIM AND MEDI-CALRX. SCR13 AB 347 AB 752. CCS WHOLE CHILD MODEL. CCS AND GHPP SARS AND ELIGIBILITY ISSUES FOR PATIENTS. | #2578521 |
| 01/01/2021–03/31/2021 | Employer Report | OTSUKA AMERICA PHARMACEUTICAL, INC. | — | CALIFORNIA STATE LEGISLATURE REGARDING AB 347, AB 593, AB 752, AB 933, AB 1130, AB 1178, AB 1252, AB 1400, AB 1468, SB 247, SB 250, SB 368, Medi-Cal: serious mental illness: drugs | #2576676 |
| 01/01/2021–03/31/2021 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 342, AB 347, AB 593, AB 752, AB 933, AB 1064, AB 1130, AB 1400, AB 1468, AB 1520, SB 247, SB 250, SB 252, SB 368 | #2579153 |
| 01/01/2021–03/31/2021 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 347, 458, 473, 568, 593, 933, 944, 839, 1400; SB 247, 368, 568 | #2581655 |
| 01/01/2021–03/31/2021 | Employer Report | Sanofi US | Sanofi US | Legislature: AB 347; AB 933. | #2580392 |
| 01/01/2021–03/31/2021 | Employer Report | UCB, Inc. | UCB, Inc. | AB 933, 458, 347, 473; SB 568, 247, 521 | #2577481 |
| 01/01/2021–03/31/2021 | Employer Report | UNITED HEALTHCARE SERVICES, INC. | — | AB 4, 6, 19, 20, 32, 71, 97, 112, 114, 243, 278, 326, 342, 347, 356, 359, 369, 370, 385, 399, 404, 450, 451, 454, 457, 458, 470, 489, 493, 521, 532, 562, 570, 586, 593, 601, 671, 685, 705, 752, 789, 797, 805, 814, 864, 875, 933, 935, 1011, 1050, 1064, 1082, 1130, 1131, 1132, 1162, 1214, 1217, 1231, 1252, 1254, 1278, 1343, 1355, 1369, 1391, 1400, 1407, 1436, 1468, 1513, 1520 | #2580087 |
| 01/01/2021–03/31/2021 | Employer Report | WESTERN CENTER ON LAW & POVERTY, INC. | — | AB:4,14,15,16,71,80,92,112,215,221,326,328,329,347,`367,368,382,412,461,470,491,493,508,510,532,540,548,550,570,572,686,721,733,771,787,803,814,838,848,854,875,907,942,950,996,1007,1011,1020,1046,1050,1094,1130+ SB:4,6,8,10,17,40,56,62,65,86,91,107,221,222,223,226,234,245,256,262,279,281,293,306,316,326,331,355,364,368,373,379,403,447,464,467,490,492,526,531,558,583,586,621,623,644,649,682,774 | #2580912 |
| 10/01/2020–12/31/2020 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2552563 |
| 07/01/2020–09/30/2020 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2527870 |
| 04/01/2020–06/30/2020 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2481856 |
| 01/01/2020–03/31/2020 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2471893 |
| 10/01/2019–12/31/2019 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2428584 |
| 07/01/2019–09/30/2019 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2418505 |
| 04/01/2019–06/30/2019 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2393118 |
| 01/01/2019–03/31/2019 | Employer Report | CALIFORNIA CATHOLIC CONFERENCE | — | AB15, AB 45, AB 175, AB211, AB347, AB348, AB415, AB524, AB539, AB573, AB612, AB624, AB628, AB629, AB715, AB721, AB732, AB809, AB842, AB892, AB944, AB959, AB960, AB965, AB972, AB987, AB987, AB1109, AB1110, AB1127, AB1354, AB410, AB1623, SB24, SB29, SB35, SB136, SB164, SB269, SB428, SB461, SB555, SB573, SB630, SB652 CONT. | #2380803 |
| 01/01/2019–03/31/2019 | Employer Report | CALIFORNIA TAX REFORM ASSOCIATION | — | AB10,AB11,AB24,AB31,AB37,AB66,AB133,AB142,AB147,AB153,AB155,AB174,AB176,AB186,AB211,AB213,AB234,AB247,AB248,AB250,AB251,AB263,AB264,AB266,AB282,AB286,AB297,AB308,AB347,AB34,AB350,AB364,AB405,AB416,AB427,AB492,AB533,AB535,AB608,AB610,AB614,AB832,AB1206,ACA1,ACA2,ACA3,SB5,SB9,SB26,SB32,SB43,SB51,SB63,SB162,SB246,SB248,SB263,SB294,SB468,SCA3,SCA4 | #2379349 |
| Period | Form | Employer | Firm / Filer | Fees | Reimb. | Period Total | Cumulative | Lobbying Activity | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 01/01/2021–03/31/2021 | Firm Activity (payments) | ALEXION PHARMACEUTICALS, INC. | KAHN CONSULTING; CHRIS | $7,000 | $0 | $7,000 | $7,000 | CALIFORNIA STATE LEGISLATURE REGARDING AB 347, AB 458, AB 752, AB 933, AB 1130, AB 1400, AB 1468, SB 247, SB 250, SB 368, SB 521. | #2579261 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | AMERICA'S HEALTH INSURANCE PLANS (AHIP) | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $31,000 | $0 | $31,000 | $31,000 | AB 32, 97, 342, 347, 454, 457, 752, 933, 935, 1011, 1254, 1400, 1520; SB 221, 242, 245, 250, 306, 368, 428, 473, 510, 523, 535, 542, 562, 613 | #2581513 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | ANTHEM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $54,000 | $0 | $54,000 | $54,000 | AB 32, 97, 342, 347, 454, 457, 752, 933, 935, 1011, 1254, 1400, 1520; SB 221, 242, 245, 250, 306, 368, 428, 473, 510, 523, 524, 535, 562, 613 | #2581513 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | Astellas Pharma US, Inc. | MANATT, PHELPS & PHILLIPS, LLP | $36,000 | $0 | $36,000 | $36,000 | AB 247, AB 347, AB 458, AB 933, SB 568 | #2580759 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | BIOCOM | TOPP STRATEGIES | $19,000 | $0 | $19,000 | $19,000 | AB 70, 97, 247, 347, 593, 933; SB 252, 255, 473, 568, 593, 605, 718; LEGISLATURE RE: BUDGET | #2579626 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | BIOGEN, INC. | ROSTRUM | $0 | $0 | $0 | $0 | AB 347, AB 752, SB 48, SB 247, SB 521; LEGISLATURE RE: GO BIZ; DEPT. OF FINANCE RE: ZERO EMISSION VEHICLES | #2576630 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | BRISTOL-MYERS SQUIBB COMPANY | POLITICAL SOLUTIONS, LLC | $29,400 | $0 | $29,400 | $29,400 | AB 347 | #2581315 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | CLEAR ADVOCACY, LLC (ON BEHALF OF SANOFI US SERVICES, INC) | JK PEDROTTI, INC. GOV'T RELATIONS | $20,000 | $0 | $20,000 | $20,000 | AB 347, AB 933 | #2580812 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | CROHN'S AND COLITIS FOUNDATION | RGS CONSULTING & ADVOCACY, LLC | $84,000 | $0 | $84,000 | $84,000 | AB 347 | #2581236 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | HEMOPHILIA COUNCIL OF CALIFORNIA | COWGER & ASSOCIATES | $15,000 | $0 | $15,000 | $15,000 | STATE BUDGET: MEDI-CAL CCS AND GHPP. TELEHEALTH PER COVID-19. CALAIM AND MEDI-CALRX. SCR13 AB 347 AB 752. CCS WHOLE CHILD MODEL. CCS AND GHPP SARS AND ELIGIBILITY ISSUES FOR PATIENTS. | #2578529 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | National Multiple Sclerosis Society | MANTELL & ASSOCIATES; MAXINE | $625 | $0 | $625 | $625 | ACR 34, AB 347, AB 752, AB 905, AB 32, AB 1130, AB 580, AB 470, CA Health and Human Services Agency and DPH on COVID vaccine prioritization recommendations | #2574212 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | NOTEWARE GOVERNMENT RELATIONS | $33,667 | $0 | $33,667 | $33,667 | AB 347, 458, 593, 933, 473, 568, 1400; SB 247, 368 | #2580173 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | FERNANDEZ CERVANTES GOVERNMENT AFFAIRS | $12,500 | $0 | $12,500 | $12,500 | AB 71, 248,249, 264, 347, 407, 458, 593, 654, 671, 789, 904, 933, 1050, 1130, 1178, 1400, SB 46, 48, 250, 252, 260, 310, 368, 521, 535, 568, 605 | #2581200 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | SANOFI US SERVICES INC. | CLEAR ADVOCACY, LLC | $20,000 | $0 | $20,000 | $20,000 | AB 347, AB 933 | #2580615 |